Literature DB >> 24281293

Urine drug testing in long-term opioid therapy: ethical considerations.

Gary M Reisfield1, Karen J Maschke.   

Abstract

As long-term opioid analgesic therapy has gained increasing clinical and societal acceptance over the past 2 decades, morbidity and mortality related to the misuse of these drugs have increased in lockstep. Hence, monitoring for opioid-related problems, largely through urine drug testing, has become a central component of risk mitigation in long-term opioid therapy. Despite the increasing use of urine drug testing, little has been written about the ethical aspects of its application. In this paper, we analyze multiple aspects of drug testing-rationale for testing, specimen collection, ordering and interpretation, and response to inappropriate test results-through the principlist lens, using the ethical principles of beneficence, nonmaleficence, justice, and autonomy.

Mesh:

Substances:

Year:  2014        PMID: 24281293     DOI: 10.1097/01.ajp.0000435448.34761.c9

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  2 in total

1.  Provider Misinterpretation, Documentation, and Follow-Up of Definitive Urine Drug Testing Results.

Authors:  Isaac Chua; Athena K Petrides; Gordon D Schiff; Jaime R Ransohoff; Michalis Kantartjis; Jocelyn Streid; Christiana A Demetriou; Stacy E F Melanson
Journal:  J Gen Intern Med       Date:  2019-11-11       Impact factor: 5.128

2.  Counselors' Clinical Use of Definitive Drug Testing Results in Their Work with Substance-Use Clients: a Qualitative Study.

Authors:  Adam Rzetelny; Barbara Zeller; Nicholas Miller; Kathy Egan City; Kenneth L Kirsh; Steven D Passik
Journal:  Int J Ment Health Addict       Date:  2015-07-21       Impact factor: 3.836

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.